Pharmacokinetics and clinical implications of semaglutide: A new glucagon-like peptide (GLP)-1 receptor agonist
Lets be clear GLP-1s were recently declared proven longevity medicine from the stage at a major industry conference in Copenhagen, which was chronicled in the journal Nature last month
The RNA-dependent condensation of G3BP is a major driver of SG assembly, and G3BP-interacting partners can influence SG dynamics by altering the SG condensation threshold ( 14 16 )
However, according to data nausea, vomiting, diarrhea, and constipation affect 40%70% of patients on GLP-1 medications
If you are using sublingual semaglutide specifically, you might wonder whether holding medication under the tongue creates higher oral fluid concentrations that could somehow interfere with testing
doi:10.1001/jamanetworkopen.2022.31982